Darren Woods, ExxonMobil chairman and CEO (left) visits Synthetic Genomics lab with SGI CEO Oliver Fetzer (right) [Synthetic Genomics image used with permission]
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.